Health Technology Assessment (HTA) is way of assessing the ways science & technology are used in healthcare and disease prevention. It covers medical, social, economic, and ethical issues.It provides policy-makers with objective information, so they can formulate health policies that are safe, effective, patient-focused and cost-effective.
Health Technology Assessment (HTA) is a multidisciplinary tool that ideally should involve patients’ perspectives; however, in reality there is still a long way to go in achieving meaningful patient involvement in HTA. EPF came to this conclusion after a seminar on HTA in 20 May 2010 and realised that patient organisations clearly needed support to be meaningfully involved in HTA processes. As a follow up of the event recommendations, EPF started conducting primary research on patient involvement in HTA since November 2010. The reports of the three main stages are currently available on the right hand menu. EPF will integrate the results of all phases in a final comprehensive report.
The aim of EPF’s research is to understand the involvement of lay patients, informal carers and patient organisations in all the EU member states and to contribute this knowledge to inform HTA – research, policy, and practice. The outcome of this research work will be a good practice toolkit to be shared with HTA agencies, patient organisations and decision making bodies in the EU.
The research involved consultation with three main stakeholders:
Through surveys and discussions, EPF collected their views, needs, ideas and expectations in shaping the role and scope of patient involvement in HTA processes. For more information, please contact Liuska Sanna, EPF programme manager.
Report: EPF survey on HTA agencies
Report: EPF survey on patients' organisations
Report: EPF survey on decision makers